Sanofi

Top biopharma CEOs sign COVID-19 vaccine safety pledge

and Sanofi and GlaxoSmithKline, the companies that are leading joint vaccine projects respectively, and stated:.

American Medical Association calls for COVID-19 vaccine development transparency

Among the companies selected to receive funding as part of the initiative includes Johnson &Johnson, AstraZeneca/Oxford University, Pfizer/BioNTech, GlaxoSmithKline/Sanofi, Moderna and Novavax.

Moderna’s COVID-19 vaccine shows promise in older adults

A number of other companies, including Johnson &Johnson, Pfizer, Novavax, AstraZeneca, GlaxoSmithKline and Sanofi, have signed similar deals with the US government.

Translate Bio, Sanofi's COVID-19 vaccine proves promising in animal studies

The US-based biotech signed a deal with Sanofi in March to jointly develop a novel mRNA-based vaccine for COVID-19. ... The expanded deal also builds upon Sanofi’s initial agreement with Translate, signed in 2018, to partner on mRNA vaccines for

COVID-19 vaccine deals with the EU hindered by strict liability rules

Meanwhile, the UK has reached deals with J&J, Novavax, GlaxoSmithKline, Sanofi and AstraZeneca/Oxford University, although the details of the liability rules within these agreements have not been disclosed.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]